Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis. - Cai H; Fang L; Lin J; Zheng Z (Frontiers in pharmacology, 2024)